nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—Etoposide—brain cancer	0.444	1	CbGbCtD
Lucanthone—APEX1—fourth ventricle—brain cancer	0.114	0.501	CbGeAlD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—brain cancer	0.0216	0.0688	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—brain cancer	0.0216	0.0688	CbGpPWpGaD
Lucanthone—APEX1—MMR—PMS2—brain cancer	0.0205	0.0653	CbGpPWpGaD
Lucanthone—APEX1—hindbrain—brain cancer	0.0155	0.0686	CbGeAlD
Lucanthone—TOP2A—Gastric Cancer Network 2—S100A6—brain cancer	0.0106	0.0339	CbGpPWpGaD
Lucanthone—APEX1—Processive synthesis on the C-strand of the telomere—PCNA—brain cancer	0.00918	0.0293	CbGpPWpGaD
Lucanthone—APEX1—brainstem—brain cancer	0.00891	0.0393	CbGeAlD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA2—brain cancer	0.0081	0.0258	CbGpPWpGaD
Lucanthone—APEX1—telencephalon—brain cancer	0.00791	0.0349	CbGeAlD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PCNA—brain cancer	0.00768	0.0245	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PCNA—brain cancer	0.00768	0.0245	CbGpPWpGaD
Lucanthone—APEX1—MMR—PCNA—brain cancer	0.00729	0.0233	CbGpPWpGaD
Lucanthone—APEX1—Processive synthesis on the lagging strand—PCNA—brain cancer	0.00729	0.0233	CbGpPWpGaD
Lucanthone—APEX1—Removal of DNA patch containing abasic residue—PCNA—brain cancer	0.00695	0.0222	CbGpPWpGaD
Lucanthone—APEX1—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—brain cancer	0.00695	0.0222	CbGpPWpGaD
Lucanthone—APEX1—gonad—brain cancer	0.0066	0.0291	CbGeAlD
Lucanthone—APEX1—pituitary gland—brain cancer	0.00644	0.0284	CbGeAlD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA2—brain cancer	0.00636	0.0203	CbGpPWpGaD
Lucanthone—APEX1—Base Excision Repair—PCNA—brain cancer	0.00636	0.0203	CbGpPWpGaD
Lucanthone—APEX1—medulla oblongata—brain cancer	0.00621	0.0274	CbGeAlD
Lucanthone—APEX1—DNA Repair—MGMT—brain cancer	0.00618	0.0197	CbGpPWpGaD
Lucanthone—APEX1—Lagging Strand Synthesis—PCNA—brain cancer	0.00587	0.0187	CbGpPWpGaD
Lucanthone—APEX1—midbrain—brain cancer	0.00568	0.025	CbGeAlD
Lucanthone—APEX1—spinal cord—brain cancer	0.00554	0.0244	CbGeAlD
Lucanthone—TOP1—telencephalon—brain cancer	0.00553	0.0244	CbGeAlD
Lucanthone—APEX1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—brain cancer	0.00546	0.0174	CbGpPWpGaD
Lucanthone—Procainamide—DNMT1—brain cancer	0.00503	0.618	CrCbGaD
Lucanthone—APEX1—endocrine gland—brain cancer	0.00499	0.022	CbGeAlD
Lucanthone—APEX1—head—brain cancer	0.00492	0.0217	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—NTRK3—brain cancer	0.00491	0.0157	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.00456	0.0146	CbGpPWpGaD
Lucanthone—APEX1—Extension of Telomeres—PCNA—brain cancer	0.00453	0.0145	CbGpPWpGaD
Lucanthone—TOP1—pituitary gland—brain cancer	0.00451	0.0199	CbGeAlD
Lucanthone—APEX1—central nervous system—brain cancer	0.00449	0.0198	CbGeAlD
Lucanthone—APEX1—cerebellum—brain cancer	0.00439	0.0194	CbGeAlD
Lucanthone—TOP1—medulla oblongata—brain cancer	0.00435	0.0192	CbGeAlD
Lucanthone—APEX1—DNA Repair—PMS2—brain cancer	0.00429	0.0137	CbGpPWpGaD
Lucanthone—APEX1—DNA strand elongation—PCNA—brain cancer	0.00419	0.0134	CbGpPWpGaD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—PCNA—brain cancer	0.00399	0.0127	CbGpPWpGaD
Lucanthone—TOP1—midbrain—brain cancer	0.00397	0.0175	CbGeAlD
Lucanthone—TOP1—spinal cord—brain cancer	0.00388	0.0171	CbGeAlD
Lucanthone—TOP2A—Teniposide—Etoposide—brain cancer	0.00364	0.5	CbGdCrCtD
Lucanthone—TOP2A—Podofilox—Etoposide—brain cancer	0.00364	0.5	CbGdCrCtD
Lucanthone—APEX1—brain—brain cancer	0.00357	0.0157	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—GFAP—brain cancer	0.00331	0.0106	CbGpPWpGaD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—PCNA—brain cancer	0.00319	0.0102	CbGpPWpGaD
Lucanthone—Amiodarone—CYP2C9—brain cancer	0.0031	0.382	CrCbGaD
Lucanthone—TOP1—cerebellum—brain cancer	0.00307	0.0136	CbGeAlD
Lucanthone—APEX1—Nucleotide Excision Repair—PCNA—brain cancer	0.00293	0.00935	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—CCNE1—brain cancer	0.00266	0.0085	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CCNE1—brain cancer	0.00265	0.00845	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00263	0.0084	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.0025	0.00797	CbGpPWpGaD
Lucanthone—TOP1—brain—brain cancer	0.0025	0.011	CbGeAlD
Lucanthone—APEX1—S Phase—SKP2—brain cancer	0.0024	0.00765	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—PCNA—brain cancer	0.00236	0.00753	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00211	0.00673	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—PCNA—brain cancer	0.00205	0.00655	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDK4—brain cancer	0.00203	0.00647	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.00194	0.0062	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.0018	0.00574	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—brain cancer	0.00178	0.00568	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—PCNA—brain cancer	0.00174	0.00555	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00173	0.00552	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—PCNA—brain cancer	0.00171	0.00546	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—APC—brain cancer	0.00171	0.00544	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.0017	0.00542	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00168	0.00535	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	0.00166	0.0053	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—PCNA—brain cancer	0.00163	0.00521	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SIRT1—brain cancer	0.00163	0.0052	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCNE1—brain cancer	0.00161	0.00514	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PPP1R12A—brain cancer	0.00161	0.00513	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	0.00157	0.00501	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00156	0.00497	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NTRK3—brain cancer	0.00153	0.00489	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—PCNA—brain cancer	0.00153	0.00487	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00149	0.00474	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00146	0.00467	CbGpPWpGaD
Lucanthone—APEX1—S Phase—PCNA—brain cancer	0.00143	0.00455	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00138	0.00439	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.0013	0.00416	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00128	0.0041	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK4—brain cancer	0.00128	0.00407	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK4—brain cancer	0.00123	0.00393	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CDK4—brain cancer	0.00123	0.00393	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00121	0.00386	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—brain cancer	0.00113	0.00361	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	0.0011	0.0035	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—brain cancer	0.00105	0.00335	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	0.00103	0.00329	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000983	0.00313	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	0.000941	0.003	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000939	0.00299	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000918	0.00293	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	0.00089	0.00284	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00087	0.00278	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	0.00087	0.00278	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—brain cancer	0.000845	0.00269	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000832	0.00265	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000829	0.00264	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—brain cancer	0.000823	0.00263	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000823	0.00263	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000821	0.00262	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—SKP2—brain cancer	0.000817	0.00261	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—brain cancer	0.000796	0.00254	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00078	0.00249	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000752	0.0024	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PPP1R12A—brain cancer	0.000744	0.00237	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	0.000731	0.00233	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—SKP2—brain cancer	0.00073	0.00233	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK6—brain cancer	0.000728	0.00232	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000723	0.00231	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000691	0.00221	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000665	0.00212	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—brain cancer	0.00066	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000659	0.0021	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK6—brain cancer	0.000651	0.00208	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000651	0.00208	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—brain cancer	0.000646	0.00206	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—brain cancer	0.000639	0.00204	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000613	0.00195	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000548	0.00175	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000546	0.00174	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—brain cancer	0.000542	0.00173	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000541	0.00173	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00053	0.00169	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000529	0.00169	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—brain cancer	0.000524	0.00167	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000524	0.00167	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	0.000509	0.00162	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—brain cancer	0.000506	0.00161	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCNE1—brain cancer	0.00049	0.00156	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000487	0.00155	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000486	0.00155	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PCNA—brain cancer	0.000486	0.00155	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000464	0.00148	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PCNA—brain cancer	0.000434	0.00139	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK4—brain cancer	0.00042	0.00134	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000405	0.00129	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000401	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00039	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CDK4—brain cancer	0.000385	0.00123	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000378	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000378	0.0012	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK4—brain cancer	0.000375	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000342	0.00109	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—SKP2—brain cancer	0.000338	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	0.000337	0.00107	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000321	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.00032	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK6—brain cancer	0.000301	0.00096	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000293	0.000935	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—brain cancer	0.000287	0.000915	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	0.000274	0.000875	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—brain cancer	0.000271	0.000865	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000259	0.000826	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000257	0.000818	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000254	0.000809	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—brain cancer	0.000242	0.000773	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—brain cancer	0.000234	0.000747	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCNE1—brain cancer	0.000227	0.000723	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000226	0.00072	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	0.000225	0.000717	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—brain cancer	0.000217	0.000694	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000208	0.000663	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000203	0.000648	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PCNA—brain cancer	0.000201	0.000641	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—brain cancer	0.000194	0.00062	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	0.000194	0.000619	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK4—brain cancer	0.000174	0.000554	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000171	0.000544	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—brain cancer	0.000164	0.000523	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—brain cancer	0.00016	0.000509	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000148	0.000473	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—brain cancer	0.000133	0.000423	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	0.000125	0.0004	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—brain cancer	0.000112	0.000358	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	0.000101	0.000321	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—brain cancer	8.99e-05	0.000287	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—brain cancer	7.39e-05	0.000236	CbGpPWpGaD
